Georgia

Georgia

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
1.48 (1.46 - 1.50) 2019 Modelled IHME
1.49 (1.48 - 1.51) 2018 Modelled IHME
1.51 (1.49 - 1.53) 2017 Modelled IHME
1.54 (1.52 - 1.56) 2016 Modelled IHME
1.57 (1.55 - 1.59) 2015 Modelled IHME
1.61 (1.59 - 1.63) 2014 Modelled IHME
1.65 (1.63 - 1.67) 2013 Modelled IHME
1.69 (1.67 - 1.71) 2012 Modelled IHME
1.73 (1.71 - 1.75) 2011 Modelled IHME
1.76 (1.74 - 1.78) 2010 Modelled IHME
1.79 (1.76 - 1.81) 2009 Modelled IHME
1.81 (1.79 - 1.83) 2008 Modelled IHME
1.83 (1.81 - 1.85) 2007 Modelled IHME
1.85 (1.82 - 1.87) 2006 Modelled IHME
1.87 (1.84 - 1.90) 2005 Modelled IHME
1.9 (1.87 - 1.93) 2004 Modelled IHME
1.93 (1.90 - 1.96) 2003 Modelled IHME
1.97 (1.93 - 2) 2002 Modelled IHME
1.99 (1.95 - 2.03) 2001 Modelled IHME
2 (1.96 - 2.04) 2000 Modelled IHME
2 (1.96 - 2.03) 1999 Modelled IHME
1.99 (1.95 - 2.02) 1998 Modelled IHME
1.97 (1.94 - 2.01) 1997 Modelled IHME
1.96 (1.93 - 2) 1996 Modelled IHME
1.95 (1.92 - 1.99) 1995 Modelled IHME
1.95 (1.91 - 1.98) 1994 Modelled IHME
1.94 (1.91 - 1.98) 1993 Modelled IHME
1.94 (1.90 - 1.98) 1992 Modelled IHME
1.94 (1.90 - 1.98) 1991 Modelled IHME
1.93 (1.89 - 1.98) 1990 Modelled IHME
2.09 (1.48 - 2.83) 2015 Modelled WHO
2.9 (2.38 - 3.51) 2017 Survey/reported Kasradze et al, 2017
2.64 (2.22 - 3.14) 2013 Modelled Schweitzer et al, 2015
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.24 (0.21 - 0.28) 2019 Modelled IHME
0.26 (0.23 - 0.28) 2018 Modelled IHME
0.26 (0.23 - 0.29) 2017 Modelled IHME
0.26 (0.23 - 0.29) 2016 Modelled IHME
0.26 (0.22 - 0.30) 2015 Modelled IHME
0.26 (0.22 - 0.30) 2014 Modelled IHME
0.27 (0.23 - 0.31) 2013 Modelled IHME
0.28 (0.24 - 0.32) 2012 Modelled IHME
0.29 (0.24 - 0.33) 2011 Modelled IHME
0.31 (0.25 - 0.34) 2010 Modelled IHME
0.34 (0.29 - 0.38) 2009 Modelled IHME
0.41 (0.35 - 0.45) 2008 Modelled IHME
0.49 (0.43 - 0.54) 2007 Modelled IHME
0.58 (0.51 - 0.64) 2006 Modelled IHME
0.67 (0.58 - 0.75) 2005 Modelled IHME
0.76 (0.64 - 0.85) 2004 Modelled IHME
0.85 (0.70 - 0.98) 2003 Modelled IHME
0.95 (0.75 - 1.11) 2002 Modelled IHME
1.05 (0.80 - 1.23) 2001 Modelled IHME
1.13 (0.86 - 1.33) 2000 Modelled IHME
1.21 (0.94 - 1.41) 1999 Modelled IHME
1.31 (1.05 - 1.49) 1998 Modelled IHME
1.39 (1.16 - 1.56) 1997 Modelled IHME
1.45 (1.24 - 1.61) 1996 Modelled IHME
1.47 (1.27 - 1.64) 1995 Modelled IHME
1.47 (1.27 - 1.63) 1994 Modelled IHME
1.47 (1.26 - 1.63) 1993 Modelled IHME
1.46 (1.24 - 1.62) 1992 Modelled IHME
1.45 (1.19 - 1.62) 1991 Modelled IHME
1.42 (1.13 - 1.63) 1990 Modelled IHME
0.26 (0.16 - 0.42) 2015 Modelled WHO
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
10 (7.31 - 13.50) 2019 Modelled IHME
9.57 (7.21 - 12.60) 2018 Modelled IHME
9.42 (7.11 - 12.30) 2017 Modelled IHME
9.7 (7.40 - 12.60) 2016 Modelled IHME
9.94 (7.63 - 12.80) 2015 Modelled IHME
10.1 (7.82 - 13.10) 2014 Modelled IHME
10.6 (8.06 - 13.70) 2013 Modelled IHME
10.9 (8.33 - 13.90) 2012 Modelled IHME
11.1 (8.53 - 14.10) 2011 Modelled IHME
11.1 (8.62 - 14.10) 2010 Modelled IHME
11.1 (8.69 - 14) 2009 Modelled IHME
11.1 (8.63 - 14) 2008 Modelled IHME
11 (8.55 - 13.90) 2007 Modelled IHME
11.2 (8.76 - 13.90) 2006 Modelled IHME
11.4 (8.80 - 14.10) 2005 Modelled IHME
11.6 (9.04 - 14.70) 2004 Modelled IHME
11.3 (8.69 - 14) 2003 Modelled IHME
11.2 (8.64 - 14) 2002 Modelled IHME
10.8 (8.40 - 13.70) 2001 Modelled IHME
10.7 (8.22 - 13.50) 2000 Modelled IHME
10.4 (7.99 - 13.20) 1999 Modelled IHME
9.76 (7.45 - 12.40) 1998 Modelled IHME
9.05 (6.82 - 11.50) 1997 Modelled IHME
8.65 (6.55 - 10.90) 1996 Modelled IHME
8.83 (6.72 - 11.20) 1995 Modelled IHME
9.25 (7.04 - 11.80) 1994 Modelled IHME
9.09 (6.81 - 11.60) 1993 Modelled IHME
9.3 (7.02 - 11.90) 1992 Modelled IHME
9.18 (6.85 - 11.80) 1991 Modelled IHME
8.97 (6.67 - 11.50) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
367 (268 - 493) 2019 Modelled IHME
354 (267 - 467) 2018 Modelled IHME
351 (265 - 459) 2017 Modelled IHME
365 (279 - 475) 2016 Modelled IHME
377 (290 - 484) 2015 Modelled IHME
388 (299 - 500) 2014 Modelled IHME
410 (311 - 531) 2013 Modelled IHME
424 (324 - 542) 2012 Modelled IHME
435 (336 - 554) 2011 Modelled IHME
443 (343 - 563) 2010 Modelled IHME
448 (351 - 566) 2009 Modelled IHME
455 (353 - 574) 2008 Modelled IHME
455 (354 - 576) 2007 Modelled IHME
472 (369 - 585) 2006 Modelled IHME
486 (377 - 604) 2005 Modelled IHME
508 (394 - 640) 2004 Modelled IHME
502 (386 - 624) 2003 Modelled IHME
508 (392 - 637) 2002 Modelled IHME
501 (389 - 634) 2001 Modelled IHME
507 (389 - 639) 2000 Modelled IHME
501 (385 - 638) 1999 Modelled IHME
480 (367 - 609) 1998 Modelled IHME
454 (342 - 575) 1997 Modelled IHME
441 (334 - 558) 1996 Modelled IHME
458 (349 - 583) 1995 Modelled IHME
487 (371 - 624) 1994 Modelled IHME
486 (364 - 623) 1993 Modelled IHME
504 (380 - 646) 1992 Modelled IHME
502 (375 - 647) 1991 Modelled IHME
494 (368 - 633) 1990 Modelled IHME
800 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
22 (16 - 30) 2019 Modelled IHME
22 (16 - 30) 2018 Modelled IHME
22 (16 - 30) 2017 Modelled IHME
22 (16 - 30) 2016 Modelled IHME
22 (16 - 30) 2015 Modelled IHME
23 (17 - 30) 2014 Modelled IHME
23 (17 - 31) 2013 Modelled IHME
23 (17 - 31) 2012 Modelled IHME
23 (17 - 31) 2011 Modelled IHME
23 (17 - 31) 2010 Modelled IHME
23 (17 - 31) 2009 Modelled IHME
23 (17 - 31) 2008 Modelled IHME
23 (17 - 31) 2007 Modelled IHME
23 (17 - 31) 2006 Modelled IHME
23 (16 - 31) 2005 Modelled IHME
23 (16 - 31) 2004 Modelled IHME
23 (17 - 32) 2003 Modelled IHME
24 (17 - 33) 2002 Modelled IHME
24 (17 - 33) 2001 Modelled IHME
24 (17 - 33) 2000 Modelled IHME
24 (17 - 33) 1999 Modelled IHME
24 (17 - 34) 1998 Modelled IHME
24 (17 - 33) 1997 Modelled IHME
24 (17 - 33) 1996 Modelled IHME
23 (17 - 32) 1995 Modelled IHME
23 (17 - 32) 1994 Modelled IHME
23 (16 - 31) 1993 Modelled IHME
23 (17 - 31) 1992 Modelled IHME
23 (16 - 31) 1991 Modelled IHME
23 (16 - 31) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
97 2018 Survey/reported WHO/UNICEF
94 2017 Survey/reported WHO/UNICEF
94 2016 Survey/reported WHO/UNICEF
93 2015 Survey/reported WHO/UNICEF
95 2014 Survey/reported WHO/UNICEF
80 2013 Survey/reported WHO/UNICEF
92 2012 Survey/reported WHO/UNICEF
93 2011 Survey/reported WHO/UNICEF
95 2010 Survey/reported WHO/UNICEF
73 2009 Survey/reported WHO/UNICEF
99 2008 Survey/reported WHO/UNICEF
99 2007 Survey/reported WHO/UNICEF
97 2006 Survey/reported WHO/UNICEF
93 2005 Survey/reported WHO/UNICEF
92 2004 Survey/reported WHO/UNICEF
90 2003 Survey/reported WHO/UNICEF
80 2002 Survey/reported WHO/UNICEF
69 2001 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
93 2018 Survey/reported WHO/UNICEF
91 2017 Survey/reported WHO/UNICEF
92 2016 Survey/reported WHO/UNICEF
94 2015 Survey/reported WHO/UNICEF
91 2014 Survey/reported WHO/UNICEF
96 2013 Survey/reported WHO/UNICEF
92 2012 Survey/reported WHO/UNICEF
89 2011 Survey/reported WHO/UNICEF
95 2010 Survey/reported WHO/UNICEF
54 2009 Survey/reported WHO/UNICEF
89 2008 Survey/reported WHO/UNICEF
94 2007 Survey/reported WHO/UNICEF
84 2006 Survey/reported WHO/UNICEF
79 2005 Survey/reported WHO/UNICEF
64 2004 Survey/reported WHO/UNICEF
48 2003 Survey/reported WHO/UNICEF
51 2002 Survey/reported WHO/UNICEF
61 2001 Survey/reported WHO/UNICEF
55 2000 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
31 (16 - 271) 2015 Survey/reported Georgia National Centre for Disease Control and Public Health, 2015; Curatio International Foundation, 2015; Eurasia Harm Reduction Network, 2015

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
3.9 (3.10 - 4.80) 2015 Survey/reported Curatio International Foundation, 2015
HBV National Action Plan
Eligible for HBV generic medicines
Source: MPP
Year of birth dose introduction
2001
Source: WHO
HepB birth dose policy
Yes
Source: WHO
HCV National Action Plan
Source:
HCV elimination goal
Source:
Year of HCV elimination goal
2030
Source:
HCV testing policy
Risk-based, Birth cohort
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
None
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
3.48 (2.81 - 4.24) 2019 Modelled IHME
3.5 (2.82 - 4.26) 2018 Modelled IHME
3.51 (2.83 - 4.27) 2017 Modelled IHME
3.49 (2.84 - 4.26) 2016 Modelled IHME
3.48 (2.85 - 4.25) 2015 Modelled IHME
3.54 (2.93 - 4.29) 2014 Modelled IHME
3.68 (3.08 - 4.40) 2013 Modelled IHME
3.85 (3.26 - 4.54) 2012 Modelled IHME
4 (3.38 - 4.67) 2011 Modelled IHME
4.06 (3.44 - 4.75) 2010 Modelled IHME
4.06 (3.44 - 4.75) 2009 Modelled IHME
4.06 (3.44 - 4.75) 2008 Modelled IHME
4.06 (3.44 - 4.74) 2007 Modelled IHME
4.06 (3.43 - 4.75) 2006 Modelled IHME
4.06 (3.41 - 4.75) 2005 Modelled IHME
4.08 (3.43 - 4.76) 2004 Modelled IHME
4.11 (3.46 - 4.80) 2003 Modelled IHME
4.14 (3.48 - 4.86) 2002 Modelled IHME
4.17 (3.49 - 4.91) 2001 Modelled IHME
4.18 (3.50 - 4.93) 2000 Modelled IHME
4.14 (3.46 - 4.85) 1999 Modelled IHME
4.03 (3.36 - 4.76) 1998 Modelled IHME
3.9 (3.21 - 4.63) 1997 Modelled IHME
3.77 (3.08 - 4.53) 1996 Modelled IHME
3.67 (2.96 - 4.47) 1995 Modelled IHME
3.61 (2.92 - 4.41) 1994 Modelled IHME
3.55 (2.88 - 4.35) 1993 Modelled IHME
3.5 (2.82 - 4.29) 1992 Modelled IHME
3.46 (2.77 - 4.25) 1991 Modelled IHME
3.43 (2.76 - 4.25) 1990 Modelled IHME
5.4 (4.60 - 6.40) 2015 Survey/reported Hagan et al, 2015
4.2 (3 - 4.20) 2015 Modelled Blach et al, 2017
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
8.9 2018 Survey/reported Averhoff A et al, 2020
6.7 (5.60 - 7.30) 2014 Modelled Gower et al, 2014
7.7 (6.70 - 8.90) 2015 Survey/reported Hagan et al, 2015
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
69.1 (58 - 80.20) 2015 Modelled Degenhardt L et al, 2017

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
10 (7.47 - 13.40) 2019 Modelled IHME
10.2 (7.72 - 13.50) 2018 Modelled IHME
10.2 (7.79 - 13.50) 2017 Modelled IHME
10.1 (7.84 - 13.10) 2016 Modelled IHME
9.71 (7.58 - 12.70) 2015 Modelled IHME
9.47 (7.33 - 12.30) 2014 Modelled IHME
9.52 (7.32 - 12.30) 2013 Modelled IHME
9.27 (7.09 - 12) 2012 Modelled IHME
9.11 (6.97 - 11.80) 2011 Modelled IHME
8.86 (6.78 - 11.50) 2010 Modelled IHME
8.5 (6.49 - 11) 2009 Modelled IHME
8.2 (6.25 - 10.50) 2008 Modelled IHME
7.82 (5.97 - 10.10) 2007 Modelled IHME
7.84 (6.06 - 10.10) 2006 Modelled IHME
7.89 (6.11 - 10) 2005 Modelled IHME
8.12 (6.32 - 10.30) 2004 Modelled IHME
8.01 (6.23 - 10.20) 2003 Modelled IHME
8.07 (6.32 - 10.20) 2002 Modelled IHME
8.06 (6.37 - 10.20) 2001 Modelled IHME
8.04 (6.36 - 10.20) 2000 Modelled IHME
7.73 (6 - 9.94) 1999 Modelled IHME
7.12 (5.46 - 9.19) 1998 Modelled IHME
6.36 (4.84 - 8.41) 1997 Modelled IHME
5.99 (4.46 - 7.94) 1996 Modelled IHME
6.01 (4.48 - 7.91) 1995 Modelled IHME
6.23 (4.62 - 8.29) 1994 Modelled IHME
6.09 (4.53 - 8.07) 1993 Modelled IHME
6.19 (4.65 - 8.42) 1992 Modelled IHME
6.07 (4.50 - 8.24) 1991 Modelled IHME
5.91 (4.30 - 8.07) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
367 (274 - 490) 2019 Modelled IHME
376 (286 - 501) 2018 Modelled IHME
381 (291 - 504) 2017 Modelled IHME
379 (295 - 494) 2016 Modelled IHME
368 (288 - 483) 2015 Modelled IHME
362 (281 - 471) 2014 Modelled IHME
367 (282 - 474) 2013 Modelled IHME
361 (276 - 467) 2012 Modelled IHME
359 (274 - 465) 2011 Modelled IHME
353 (270 - 457) 2010 Modelled IHME
343 (262 - 442) 2009 Modelled IHME
335 (256 - 430) 2008 Modelled IHME
324 (248 - 417) 2007 Modelled IHME
330 (255 - 424) 2006 Modelled IHME
338 (261 - 429) 2005 Modelled IHME
354 (276 - 450) 2004 Modelled IHME
356 (277 - 452) 2003 Modelled IHME
366 (287 - 463) 2002 Modelled IHME
374 (295 - 473) 2001 Modelled IHME
380 (301 - 482) 2000 Modelled IHME
373 (290 - 479) 1999 Modelled IHME
351 (269 - 452) 1998 Modelled IHME
319 (243 - 422) 1997 Modelled IHME
306 (227 - 405) 1996 Modelled IHME
312 (232 - 410) 1995 Modelled IHME
329 (243 - 437) 1994 Modelled IHME
326 (243 - 431) 1993 Modelled IHME
335 (252 - 456) 1992 Modelled IHME
332 (246 - 451) 1991 Modelled IHME
325 (237 - 445) 1990 Modelled IHME
425 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
34 (25 - 43) 2019 Modelled IHME
34 (26 - 43) 2018 Modelled IHME
34 (26 - 43) 2017 Modelled IHME
35 (26 - 44) 2016 Modelled IHME
35 (26 - 44) 2015 Modelled IHME
35 (26 - 44) 2014 Modelled IHME
35 (26 - 44) 2013 Modelled IHME
35 (27 - 44) 2012 Modelled IHME
36 (27 - 44) 2011 Modelled IHME
36 (27 - 45) 2010 Modelled IHME
36 (27 - 45) 2009 Modelled IHME
36 (27 - 45) 2008 Modelled IHME
36 (27 - 46) 2007 Modelled IHME
37 (28 - 46) 2006 Modelled IHME
38 (28 - 46) 2005 Modelled IHME
38 (28 - 47) 2004 Modelled IHME
37 (28 - 47) 2003 Modelled IHME
37 (27 - 47) 2002 Modelled IHME
37 (28 - 47) 2001 Modelled IHME
37 (27 - 47) 2000 Modelled IHME
37 (28 - 47) 1999 Modelled IHME
37 (27 - 47) 1998 Modelled IHME
37 (28 - 47) 1997 Modelled IHME
37 (28 - 47) 1996 Modelled IHME
37 (28 - 47) 1995 Modelled IHME
37 (28 - 47) 1994 Modelled IHME
37 (28 - 47) 1993 Modelled IHME
37 (28 - 46) 1992 Modelled IHME
37 (28 - 46) 1991 Modelled IHME
37 (28 - 46) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
31 (16 - 271) 2015 Survey/reported Georgia National Centre for Disease Control and Public Health, 2015; Curatio International Foundation, 2015; Eurasia Harm Reduction Network, 2015

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
3.9 (3.10 - 4.80) 2015 Survey/reported Curatio International Foundation, 2015
HBV National Action Plan
Eligible for HBV generic medicines
Source: MPP
Year of birth dose introduction
2001
Source: WHO
HepB birth dose policy
Yes
Source: WHO
HCV National Action Plan
Source:
HCV elimination goal
Source:
Year of HCV elimination goal
2030
Source:
HCV testing policy
Risk-based, Birth cohort
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
None
Source: WHO

Overview

HCV elimination goal
Year of goal
2030

Prevalence (national)

Modelled

HBV (HBsAg+)
1.48 (%)
2019
(1.46 - 1.5(%))
IHME
HCV (RNA/cAg+)
3.48 (%)
2019
(2.81 - 4.24(%))
IHME

Survey/surveillance

HBV (HBsAg+)
2.9 (%)
2017
(2.38 - 3.51(%))
Kasradze et al, 2017
HCV (anti-HCV)
8.9 (%)
2018
Averhoff A et al, 2020

Hepatitis related deaths (national)

Modelled

HBV
367
2019
(268 - 493)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
367
2019
(274 - 490)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.24 (%)
2019, latest modelled
(0.21 - 0.28(%))
IHME

Prevalence PWID

HCV
69.10 (%)
2015, latest modelled
(58 - 80.20(%))
Degenhardt L et al, 2017

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
97 (%)
2018
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
31
2015
(16 - 271)
Georgia National Centre for Disease Control and Public Health, 2015; Curatio International Foundation, 2015; Eurasia Harm Reduction Network, 2015
Eligible for HBV generic medicines
Eligible for HCV generic medicines
Health minister of GA
group photo
cake with Stop C
Previous Next

Resources